Inmunoterapia en el tratamiento del cáncer de cabeza y cuello

Previous Page

Next Page

Page Background

ASCO 2016

6

Study

First

Author

SCCHN

Presentation

Type

Slide

Range

CheckMate

141

Ferris

Further Evaluations of Nivolumab Versus Investigator’s Choice Chemotherapy for

Recurrent or Metastatic (R/M) Squamous Cell Carcinoma of the Head and Neck

(SCCHN): CheckMate 141

Oral

385-406